Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Abrupt Discontinuation of the Codman Hepatic Artery Infusion Pump: Considerations in the Era of Precision Medicine

(2019) Ryan J. Ellis et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands

(2019) Florian E. Buisman et al.   ANNALS OF SURGICAL ONCOLOGY

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

(2018) John M. Creasy et al.   SURGERY

Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases

(2018) Jeffery Chakedis et al.   JOURNAL OF SURGICAL ONCOLOGY

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential

(2017) Linda M. Pak et al.   JOURNAL OF SURGICAL ONCOLOGY

Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case–Control Study

(2016) Mashaal Dhir et al.   ANNALS OF SURGICAL ONCOLOGY

Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies

(2016) Andrea Cercek et al.   JOURNAL OF SURGICAL ONCOLOGY

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

(2015) Michael I. DʼAngelica et al.   ANNALS OF SURGERY

Variations in Metastasis Site by Primary Location in Colon Cancer

(2015) Ramzi Amri et al.   JOURNAL OF GASTROINTESTINAL SURGERY

What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up

(2015) Carlo Pulitanò et al.   HPB

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial

(2014) T. Gruenberger et al.   ANNALS OF ONCOLOGY

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

(2009) Gunnar Folprecht et al.   LANCET ONCOLOGY

Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity

(2008) Luca Viganò et al.   ANNALS OF SURGICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY